Celldex Therapeutics | CLDX - Gross Profit On Sales

Stock Price
29.37
Daily Change
-0.17 -0.58%
Monthly
23.61%
Yearly
37.69%
Q1 Forecast
29.17

Celldex Therapeutics reported $121K in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Agenus USD 23.93M 2.79M Mar/2025
Amgen USD 6.48B 307M Sep/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Celldex Therapeutics USD 121K 609K Dec/2025
Glaxosmithkline GBP 8.75B 2.92B Sep/2025
Nektar Therapeutics USD 13.75M 650K Jun/2024
Pfizer USD 3.54B 7.61B Sep/2025
Rigel Pharmaceuticals USD 28.49M 7.01M Jun/2024
Roche Holding CHF 22.09B 10.04B Dec/2025